While this happened, Ladenburg Thalmann initiated its Aptevo Therapeutics Inc [APVO] rating to a Buy in a research note published recently.
Price Performance Review of APVO
On Tuesday, Aptevo Therapeutics Inc [NASDAQ:APVO] saw its stock fall -7.52% to $0.57. Over the last five days, the stock has lost -18.37%. Aptevo Therapeutics Inc shares have fallen nearly -86.87% since the year began. Nevertheless, the stocks have fallen -97.75% over the past one year. While a 52-week high of $51.06 was reached on 01/07/25, a 52-week low of $0.60 was recorded on 04/29/25. SMA at 50 days reached $1.9787, while 200 days put it at $7.3443.
Levels Of Support And Resistance For APVO Stock
The 24-hour chart illustrates a support level at 0.5368, which if violated will result in even more drops to 0.5077. On the upside, there is a resistance level at 0.6044. A further resistance level may holdings at 0.6429. The Relative Strength Index (RSI) on the 14-day chart is 28.86, which indicates oversold technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.1937, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 97.52%. Stochastics %K at 3.86% indicates the stock is a buying.
How much short interest is there in Aptevo Therapeutics Inc?
A steep rise in short interest was recorded in Aptevo Therapeutics Inc stocks on 2025-04-15, growing by 0.58 million shares to a total of 0.7 million shares. Yahoo Finance data shows the prior-month short interest on 2025-03-14 was 0.12 million shares. There was a rise of 82.86%, which implies that there is a positive sentiment for the stock.
